I
nnate and adaptive components of the cellular immune system function sequentially to provide protection against microbial infection. Unlike conventional CD4 and CD8 T cells, which must undergo clonal expansion in response to infection, NK cells expressing germ line-encoded receptors respond rapidly to kill infected cells or release cytokines and provide the initial defense during infection. To kinetically bridge the innate and adaptive responses, innate T cells, such as invariant natural killer T (iNKT) cells and M3-restricted T cells, respond more quickly than conventional T cells to infection. Innate T cells are less dependent upon clonal expansion than conventional CD4 and CD8 T cells, because they appear to detect molecular patterns or danger signals rather than specific peptides bound to polymorphic major histocompatibility complex (MHC) molecules. For example, iNKT cells use an invariant T-cell receptor alpha (TCR␣) chain (V␣24-J␣18 in humans and the homologous V␣14-J␣18 in mice) combined with a limited set of TCR␤ chains to detect the nonclassical MHC class I (class Ib) molecule CD1d, which binds an assortment of self and microbial lipid antigens. However, iNKT cells display little antigen discrimination, since the invariant TCR␣ chain primarily engages the CD1d-lipid complex while the TCR␤ chain makes limited contact (6) . Additionally, iNKT cell activation can occur by various pathways, some of which do not require the iNKT detection of CD1d (8, 74) . Therefore, with a limited TCR repertoire, iNKT cells can rapidly secrete cytokines in response to a wide range of infections by bacterial, viral, protozoan, or fungal pathogens. The immunomodulatory role of iNKT cells is well established, but the physiological role of iNKT cells in host immunity remains incompletely understood (4, 69) . Mucosa-associated invariant T (MAIT) cells, a recently identified T-cell subset in mammals, share striking similarities and interesting differences with iNKT cells (73) . MAIT cells have been implicated recently in detection of diverse microbial infections (33, 50) , raising important questions of whether and how they might function in pathogen protection as an addition to the innate T-cell population.
Unlike iNKT cells, MAIT cells preferentially reside in mucosal tissues, and their homotypic expansion is dependent upon commensal microbes (72) . In addition, MAIT cells are more abundant in humans than mice, whereas iNKT cells are more abundant in mice than humans (73) . Similar to iNKT cells, MAIT cells express an invariant TCR that recognizes a novel nonpolymorphic class Ib molecule. More specifically, MAIT cells express an invariant TCR␣ chain (V␣7.2-J␣ 33 in humans and the homologous V␣19-J␣33 in mice) that is preferentially associated with certain TCR␤ chains (V␤2, V␤13, and V␤22 in humans and V␤6 and V␤8 in mice) (45, 71) . Most mouse MAIT cells are CD4/CD8 double negative (DN), but some are also singly positive for CD8 or CD4 coreceptors (45, 55, 72) . Human MAIT cells have been reported in either the DN or CD8 ϩ subsets (33, 55, 71) . The developmental selection and peripheral activation of MAIT cells is restricted by the nonpolymorphic class Ib molecule MHC-related protein 1 (MR1) (72) . The selection of MAIT cells in the thymus requires the expression of MR1 on hematopoietic cells, likely including double-positive (DP) thymocytes, macrophages (M⌽), and dendritic cells (DCs) (13, 55, 72) . The Mr1 gene is highly conserved among mammals (64, 78, 79) . The predicted amino acid sequences of mouse and human MR1 are 89%/90% identical in their ␣1/␣2 domains. In contrast, mouse and human CD1 ␣1/␣2 domains are only 60%/62% identical (38) . Interestingly, the sequence analysis of Mr1 gene orthologs has indicated their strong purifying selection during evolution, suggesting their physiological importance (41) . In functional support of this conclusion, mouse and human MAIT cells, like iNKT cells, have the ability to be activated in a cross-species manner (41) .
The notion that MR1 presents antigen to MAIT cells is supported by extensive mutagenesis studies (39, 56) as well as by the fact that all ␣␤ T cells characterized thus far detect MHC or MHClike molecules bound by antigen. What is known about the MR1 presentation pathway is that MAIT cell development and activation is independent of transporters associated with antigen processing (TAP) (40, 71) . Moreover, the activation of mouse MAIT cell hybridomas by MR1-overexpressing cell lines was found to be proteasome independent and enhanced by endocytic trafficking (40) . Thus, MR1 clearly does not use the same antigen presentation pathway as classical MHC class I (class Ia) molecules. More interestingly, unlike class Ia or CD1 molecules, which are constitutively expressed on the plasma membranes of antigen-presenting cells (APCs), MR1 proteins reside mostly in the endoplasmic reticulum (ER), and only low levels have been detected at the plasma membrane (13, 35, 40) . However, surface expression of mouse MR1 can be stabilized at the cell surface using selective monoclonal antibodies (MAbs) (13), whereas human MR1 was shown to be inducible on a human lung epithelial cell line after in vitro infection with Mycobacterium tuberculosis (33) . Collectively, these findings demonstrate that MR1 activation of MAIT cells represents a novel and unique mechanism of ␣␤ T-cell activation that has been conserved throughout mammalian evolution, suggesting physiologic importance in host immunity.
In support of their physiologic importance, two recent studies showed that human and mouse MAIT cells can detect microbial infection in an MR1-restricted manner (33, 50) . In a human study, Gold et al. cloned M. tuberculosis-reactive CD8 ϩ T cells from infected and uninfected individuals and found in both populations that a high frequency of the M. tuberculosis-reactive T cells are human MR1-restricted MAIT cells (33) . Furthermore, these M. tuberculosis-reactive human MAIT cells are also activated by APCs infected with other bacterial strains, including Escherichia coli, Salmonella enterica serovar Typhimurium, and Staphylococcus aureus but not Listeria monocytogenes. A concomitant study by Le Bourhis et al. showed that both mouse and human MAIT cells display activation markers after in vitro coculture with APCs infected with various strains of bacteria and yeasts but not viral pathogens (50) . This highly cross-reactive recognition of microbial-infected APCs by MAIT cells suggests that their activation may be more similar to pattern recognition than ligand discrimination. However, the upregulation of activation markers on MAIT cells was found not to be dependent upon known innate receptors or adaptors, including Toll-like receptors (TLRs), Nodlike receptors, MyD88, and TRIF (50) . In contrast, innate receptor pathways have been shown to be important in iNKT cell activation both in vivo and in vitro (8, 9, 15, 59, 74, 75) . Regarding the clinical relevance of MAIT cells, the two studies mentioned above reported that patients with ongoing M. tuberculosis infection have fewer MAIT cells in the blood and higher levels in the lung than healthy individuals (33, 50 (32) . It is unclear why in vitro activation experiments showed that mouse MAIT cells respond to APCs infected with diverse microbes, yet most in vivo experiments showed that MR1 Ϫ/Ϫ mice which lack MAIT cells are not impaired in their ability to control infection with most bacterial strains tested. A possible explanation of this conundrum is that WT mice lack a sufficient number of MAIT cells to show an antibacterial phenotype. Consistent with this explanation, V␣19-J␣33 TCR-transgenic mice that overexpress MAIT cells had lower bacterial loads than control mice after infection with E. coli or M. abscessus (50) . However, because the TCR-transgenic mice used in these comparisons have few if any conventional CD4 ϩ and CD8 ϩ T cells, this model system lacks physiologic context or the ability to address the question of whether MAIT cells have a nonredundant role in controlling bacterial infection (12) . Another possible explanation to the inconsistency between in vivo and in vitro studies is that perhaps an infection model in mucosal tissues, where MAIT cells mainly reside, needs to be employed. To our knowledge, in vivo infections that have been reported so far to compare MR1 Ϫ/Ϫ and WT mice are conducted through intraperitoneal injection (32, 50) . The in vivo role of MAIT cells may be overlooked in the systemic challenge and therefore did not provide results that correlated with the in vitro reactivity to diverse microbes.
To determine whether MAIT cells function as innate T cells and what unique role they might play in bacterial infection, we employed in vitro and in vivo assays and identified a robust phenotype. Using the Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in vitro, we showed that MAIT cells secrete gamma interferon (IFN-␥), which enhances the antibacterial activity of infected M⌽ in a manner dependent upon IL-12/23p40. Unexpectedly, the antibacterial activity in these in vitro assays was found to be largely independent of MR1 expression by infected M⌽, even though MR1 expression is required during ontogeny for MAIT cells to acquire their innate function. Furthermore, our in vivo studies using low-dose aerosol challenge showed that MR1 Ϫ/Ϫ mice had significantly higher bacterial loads in the lung after mycobacterial infection than WT mice. These findings demonstrate that the antibacterial activity of MAIT cells is unique and not redundant with the activities of other innate T-cell populations in the immune system.
MATERIALS AND METHODS

Mice. C57BL/6 and IL-12/23p40
Ϫ/Ϫ mice were purchased from The Jackson Laboratory. MR1 Ϫ/Ϫ , V␣19iTgMR1 ϩ/ϩ , and V␣19iTgMR1 Ϫ/Ϫ mice (all C57BL/6 background) were gifts from S. Gilfillan (Washington University). The V␣19i transgene in these mice is the canonical TCR V␣ of MAIT cells shared by Ͼ90% of mouse MAIT cells, and MAIT cells isolated from the transgenic mice used in this study have limited endogenous TCR V␤ usage and surface marker characteristics of polyclonal MAIT cells (45) . Mice were bred and maintained under specific-pathogen-free conditions and were used by protocols in the studies approved by the Animal Studies Committee of Washington University.
Antibodies and cytokine. Anti-MR1 MAbs 26.5 and 8F2.F9 were reported previously (13, 39) and used as a mixture in the in vitro cultures. Anti-IFN-␥ (H22) was a gift from R. Schreiber (Washington University). Anti-IL-12/23p40 MAb (C17.8) was purchased from R&D Systems (Minneapolis, MN). Anti-IL17A (18H10) was purchased from Mabtech (Mariemont, OH). All antibodies were used at the concentration of 10 g/ml in the in vitro cultures. Recombinant mouse IL-12 was purchased from Peprotech (Rocky Hill, NJ) and reconstituted according to the instructions.
T-cell isolation. Spleen cells from naïve mice were aseptically removed and used as the source for T-cell isolation. A single-cell suspension was prepared, and red blood cells were lysed with ammonium chloride. Cells were washed, counted, and subjected to magnetic labeling and separation according to the instructions of the pan-T-cell isolation kit II (130-095-130; Miltenyi Biotec, Auburn, CA). The enriched T cells were used in the in vitro cultures.
In vitro analysis of the inhibition of intracellular M. bovis BCG growth in M⌽ by T cells. The procedures for analyzing the inhibition of intracellular M. bovis BCG growth in M⌽ by T cells, including the in vitro culture of bone marrow-derived M⌽, the infection of mycobacteria, the coculture of M⌽ and T cells, and the measurement of intracellular bacterial growth, were adopted and modified from published reports and protocols (18, 26, 61, 77) . In brief, bone marrow was flushed from femurs of mice with D10 medium, which is Dulbecco's modified Eagle medium (DMEM) (Gibco, Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum (HyClone, Logan, UT), 2 mM L-glutamine (Mediatech, Manassas, VA), 10 mM HEPES buffer (Mediatech, Manassas, VA), 1ϫ nonessential amino acids (Mediatech, Manassas, VA), 1 mM sodium pyruvate (Mediatech, Manassas, VA), 100 U/ml penicillin, and 100 g/ml streptomycin. Red blood cells were lysed, and the remaining bone marrow cells were washed and plated at 2 ϫ 10 4 viable cells per well in 96-well plates (flat bottom) in D10 medium supplemented with 20 ng/ml recombinant murine macrophage colony-stimulating factor (rmM-CSF; 315-02; Peprotech, Rocky Hill, NJ). Cells were incubated at 37°C in 5% CO 2 . After 3 days, the attached cells were gently washed with warm antibiotic-free D10 Ϫ medium (D10 medium without penicillin and streptomycin). The attached cells were cultured in D10 Ϫ medium containing fresh rmM-CSF (20 ng/ml) for an additional 4 days at 37°C in 5% CO 2 . After the 7-day culture period, bone marrow-derived M⌽ formed a confluent monolayer, and the density of M⌽ was estimated to be 2 ϫ 10 5 cells per well in 96-well plates. M⌽ were infected with M. bovis BCG (Danish strain) at a multiplicity of infection (MOI) of 3:1 (bacteria to M⌽) in D10
Ϫ medium at 37°C in 5% CO 2 . After overnight culture, infected M⌽ were washed with D10 Ϫ medium to remove the extracellular M. bovis BCG before coculture with purified T cells. Purified T cells were obtained as described above and added to the wells of infected M⌽ at the ratio of 1:1 in D10
Ϫ medium at 37°C in 5% CO 2 for 72 h. At the end of coculture, supernatants were collected for the measurement of the production of cytokines and nitric oxide. Cells were lysed with 0.2% saponin to release intracellular M. bovis BCG. Mycobacteria were radiolabeled with tritiated uridine as previously described (77) to determine the viability of bacteria under different coculture conditions. Briefly, [5,6- 3 H]uridine (Perkin Elmer, Waltham, MA) at 1 Ci/ml prepared in Middlebrook 7H9 broth supplemented with 10% ADC enrichment medium (BD BBL 211887; Becton, Dickinson, Franklin Lakes, NJ) was added to saponin lysates. After incubation at 37°C for 72 h, the tritiated uridine-pulsed mycobacteria were harvested (Tomtec Harvester 96 MACH III M; Tomtec, Hamden, CT) onto glass fiber filters (Perkin Elmer, Waltham, MA), and radioactivity was quantitated by liquid scintillation counting (Wallac MicroBeta TriLux 1450; Perkin Elmer, Waltham, MA). The percentages of M. bovis BCG growth inhibition under different coculture conditions were calculated by the following formula: percent inhibition ϭ 100 Ϫ [100 ϫ (disintegrations per minute from T cell-infected M⌽ cocultured wells/disintegrations per minute from infected M⌽ alone wells)].
Measurement of cytokine and nitric oxide (NO) production. Culture supernatants were collected after 72 h of coculture. The concentration of IFN-␥ and IL-17A was quantified by standard sandwich ELISAs according to the manufacturer's instruction (R&D Systems, Minneapolis, MN). NO production was measured by the Griess reaction, using commercial Griess reagent (G4410; Sigma-Aldrich, St. Louis, MO). Serially diluted NaNO 2 (S-2252; Sigma-Aldrich, St. Louis) (0 to 100 M) was used to generate a standard curve to quantify the amount of nitrite (NO 2 Ϫ ) in supernatants (37, 57, 62) .
In vivo infection of M. bovis BCG. WT and MR1 Ϫ/Ϫ mice were infected with M. bovis BCG (Danish strain) via aerosol or the intranasal route. In the aerosol infection, M. bovis BCG was diluted to 10 7 CFU/ml in phosphate-buffered saline (PBS) with 0.04% Tween 80. A nebulizer (bioaerosol nebulizing generator [BANG]; CH Technologies) was set to liquid feed at 1 ml/min and airflow at 1 liter/min to expose mice to M. bovis BCG. A 20-min exposure to the aerosol resulted in the delivery of 100 to 300 infectious bacilli per mouse lung. In the intranasal infection, WT and MR1 Ϫ/Ϫ mice were injected with M. bovis BCG via the nares (10 7 CFU per mouse) while mice were under anesthesia and laid on their dorsal side on a plastic mouse holder (60). On day 10 and 30 postinfection, the lungs were harvested and homogenized. To determine the mycobacterial colonization, the lung homogenate was serially diluted (1:10 and 1:100) and plated on Middlebrook 7H10 agar plates supplemented with 10% OADC (oleic acid-albumin-dextrose-catalase) enrichment medium (BD BBL 212240; Becton, Dickinson, Franklin Lakes, NJ). Two to three weeks later, mycobacterial CFU had formed on the agar plates and were counted.
Ex vivo stimulation of bronchoalveolar lavage (BAL) cells by mycobacterial antigens and IFN-␥ enzyme-linked immunosorbent spot (ELISPOT) analysis. To determine the IFN-␥ response elicited in the lung by M. bovis BCG infection, bronchoalveolar lavage (BAL) cells from WT and MR1
Ϫ/Ϫ mice were harvested. BAL cells from the same genotype were pooled and used in the ELISPOT assay. The BAL cells were stimulated ex vivo with M. bovis BCG (MOI ϭ 3) or various antigens derived from M. tuberculosis, including culture filtrate proteins (CF) (10 g/ml; Colorado State University, Fort Collins, CO), cell wall (CW) fraction (50 g/ml; Colorado State University, Fort Collins, CO), and the Ag85B peptide pool (Ag85Bpp) (2 g/ml; JPT Peptide Technologies GmbH, Berlin, Germany). The frequency of IFN-␥-producing cells in the BAL cells was measured by ELISPOT analysis. Anti-IFN-␥ MAbs, clones AN18 and R4-6A2 (biotinylated), were purchased from eBioscience (San Diego, CA) and used as a pair to capture the release of IFN-␥ of BAL cells. Streptavidinalkaline phosphatase (ALP) (Mabtech, Mariemont, OH) and BCIP/NBT (5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium) substrate (Fisher Scientific, Pittsburgh, PA) were used to visualize the IFN-␥ spot-forming units (SFUs). A CTL-ImmunoSpot S6 microanalyzer and ImmunoSpot professional software (Shaker Heights, OH) were used to quantitate the SFUs.
RESULTS
MR1-restricted MAIT cells have an innate function and inhibit mycobacterial growth in M⌽.
To define the potential role of MAIT cells in controlling bacterial infection, we established an in vitro infection assay whereby purified MAIT cells were cocultured with M. bovis BCG-infected M⌽. In these coculture assays, purified transgenic MAIT cells composed of 50% of DN, 25% CD8 ϩ , and 25% CD4 ϩ T cells (45) (data not shown) from naïve V␣19iTgMR1 ϩ/ϩ mice were used. As a negative control, purified naïve T cells from V␣19iTgMR1 Ϫ/Ϫ mice were included (45) . In these mice, T cells that express the V␣19-J␣33 transgene are found in the periphery, but due to the lack of selection by MR1 during development, these T cells do not display MAIT cell characteristics, including cytokine secretion, effector/memory phenotype, and bias in the TCR␤ usage (45, 55) . For comparisons, we also included naïve T cells from WT mice that have a very low frequency of MAIT cells and from MR1 Ϫ/Ϫ mice that lack detectable MAIT cells (72) . These various populations of naïve T cells were cocultured with M. bovis BCG-infected M⌽. As shown in Fig. 1a and b, MAIT cells inhibited the intracellular growth of M. bovis BCG in M⌽ by 40 to 80% (varying in several independent experiments) compared to bacterial growth in M⌽ in the absence of MAIT cells. Importantly, control transgenic T cells from V␣19iTgMR1 Ϫ/Ϫ mice showed no inhibition of bacterial growth in M. bovis BCG-infected M⌽ (Fig. 1a and b) . Thus, the antibacterial function of V␣19-J␣33 TCR-bearing T cells requires MR1 selection during development. T cells from naïve MR1
Ϫ/Ϫ and WT mice also failed to inhibit the intracellular growth of M. bovis BCG in M⌽, suggesting that normal levels of MAIT cells or other innate T cells are not sufficient to control the mycobacterial growth in these coculture assays (Fig. 1a and b) . In addition, MAIT cells, but not control transgenic T cells, enhanced nitric oxide (NO) production by infected M⌽ (Fig. 1c) , indicating an increase in microbicidal activity of M⌽ and providing further evidence of the ability of MAIT cells to control bacterial infection.
MAIT cells are a potent source of innate IFN-␥. IFN-␥ is a key cytokine for optimal antimycobacterial immunity (16, 28, 29) . In the early stage of infection, innate T cells and NK cells are activated by mycobacterium-infected M⌽ to release IFN-␥ (27, 49, 66) . This innate source of IFN-␥ is indispensable for enhancement in bactericidal activity of M⌽, including the induction of inducible nitric oxide synthase (iNOS) (54) . It has been shown that human MAIT cells produce IFN-␥ in response to mycobacterium-infected APCs (33, 50) . However, whether IFN-␥ production is required for MAIT cells to control mycobacterial growth was not previously investigated. To address this question, we first determined whether mouse MAIT cells secrete IFN-␥ when cocultured with M. bovis BCG-infected M⌽. As shown in Fig. 2a , MAIT cells responding to infected M⌽ had high levels of IFN-␥ production. In contrast, the supernatant from the cocultures of V␣19iTgMR1 Ϫ/Ϫ , WT, or MR1 Ϫ/Ϫ T cells showed low, if any, IFN-␥ production (Fig. 2a) . To test whether IFN-␥ production by MAIT cells was required for the control of mycobacterial growth, anti-IFN-␥ blocking antibody was added to the coculture. Anti-IFN-␥ antibody ablated the inhibition of bacterial growth by MAIT cells (Fig. 2b) and also suppressed the enhancement of NO production by MAIT cells (Fig. 2c) . These findings suggested that MAIT cells are a potent source of innate IFN-␥ which is required for their ability to control mycobacterial growth in M⌽.
Activated MAIT cells produce IL-17A in response to infection. In addition to IFN-␥, MAIT cells have also been reported to produce IL-17 in response to mitogenic or cytokine stimulations (10, 25) . These finding raise the question of whether MAIT cells secrete IL-17 when encountering bacterium-infected APCs. As shown in Fig. 3a , MAIT cells produced high levels of IL-17A when cocultured with M. bovis BCG-infected, but not uninfected, M⌽. To determine whether IL-17A secretion was required for MAIT cell control of the intracellular growth, an anti-IL-17A blocking antibody was added to the coculture. Interestingly, the blockage of IL-17 in the coculture did not affect the ability of MAIT cells to control the intracellular growth of M. bovis BCG in M⌽ (Fig. 3b) . The combined results ( Fig. 2 and 3) suggest that during infection, MAIT cells produce IFN-␥ to provide direct control of bacterial growth in infected APCs, whereas their IL-17 production may help stimulate the adaptive immune response (see below).
Effector function of MAIT cells is dependent on the innate signal IL-12 from infected M⌽. Next, we sought to dissect the mechanism by which APCs activate MAIT cells during infection. iNKT cells can receive two signals from APCs during infection (8, 74) . One signal is the cognate interaction between CD1d/lipid complexes on APCs and TCRs on iNKT cells (6) , whereas the more dominant signal was recently shown to be IL-12 secretion by the microbe-infected APCs (9) . Our results have demonstrated that MR1 is required for MAIT cells during development to obtain their effector function ( Fig. 1 and 2a; also, see Fig. S1 in the supplemental material). To determine if cognate recognition of MR1 on infected M⌽ is required for MAIT cell activation, anti-MR1 blocking MAbs (13, 33, 39, 50) 
or MR1
Ϫ/Ϫ M⌽ were used in the coculture assay. Surprisingly, anti-MR1 MAbs did not block MAIT cell production of IFN-␥ and IL-17A (Fig. 4a and c) or enhancement of NO production (Fig. 4e) when cocultured with WT M⌽ infected with M. bovis BCG. Furthermore, MR1
Ϫ/Ϫ M⌽ infected with M. bovis BCG elicited MAIT cell responses comparable to those obtained with infected WT M⌽ (Fig. 4b, d, and f) . Thus, the cognate recognition of MR1 on infected cells was not required for MAIT cytokine responses to infected APCs.
To determine whether the IL-12 signal from infected APCs was responsible for MAIT cell activation, we took advantage of anti-IL-12/23p40 blocking MAb and M⌽ from mice deficient in the IL-12/23p40 gene (p40 Ϫ/Ϫ ). The coculture experiments showed that WT M⌽ infected with M. bovis BCG failed to activate MAIT cells in the presence of anti-IL-12/23p40 MAb (Fig. 4a, c , and e). Furthermore, p40 Ϫ/Ϫ M⌽ infected with M. bovis BCG did not elicit IFN-␥ or IL-17A production ( Fig. 4b and d) or support enhancement of NO production by MAIT cells (Fig. 4f) .
We next tested whether MR1-recognition and IL-12 secretion were required for the ability of MAIT cells to control the intracellular bacterial growth in infected M⌽. As shown in Fig. 5a and c, anti-IL-12/23p40 MAb blocked the anti-bacterial activity of MAIT cells, but anti-MR1 MAbs did not (Fig. 5a and c) . Furthermore, MAIT cells were not able to control bacterial growth in p40 Ϫ/Ϫ M⌽ but were still effective in inhibiting bacterial growth Ϫ in supernatants was measured. Results are the means Ϯ SEM from triplicate assays of each set of culture conditions. Statistical analysis was performed using a oneway ANOVA with Tukey's multiple comparison posttest comparing all culture conditions (*, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001; ns, not significant). Data are results from one of three independent experiments. 
in MR1
Ϫ/Ϫ M⌽ ( Fig. 5b and d) . The MAIT cell dependence on IL-12 was also revealed by the addition of anti-IL-12/23p40 MAb to the coculture with MR1 Ϫ/Ϫ M⌽ infected with M. bovis BCG, where MAIT cell activation and effector function were blocked (data not shown). Thus, these in vitro findings highlight the im- portance of MAIT cell control of intracellular bacterial growth in M⌽ by a mechanism that is IL-12 dependent and show that in the presence of an innate IL-12 signal, the requirement for cognate engagement of MR1 by MAIT cells was not detected.
The above observations indicated that the IL-12 signal rather than MR1 recognition may dominate MAIT cell activation and effector function in bacterial infection. However, it remained possible that an MR1-restricted interaction between MAIT cells and M⌽ may be masked by a strong IL-12 signal. To test this possibility, we added anti-MR1 MAbs to the coculture of MAIT cells and p40 Ϫ/Ϫ M⌽ infected with M. bovis BCG. As shown in Fig. 6a and b, anti-MR1 MAbs further decreased the already defective production of IFN-␥ and IL-17A by MAIT cells in the absence of IL-12 signal from infected M⌽. However, the decrease in MAIT cell cytokine production by anti-MR1 MAbs was not reflected in the control of M. bovis BCG growth in p40 Ϫ/Ϫ M⌽ (Fig. 6c) . These data suggested that the MR1/TCR-mediated signal may be weak and/or transient. IL-12 was shown to amplify weak TCR-mediated activation of iNKT cells (9) . The addition of recombinant IL-12 stimulated MAIT cells cocultured with uninfected WT M⌽ to release IFN-␥ in a dose-dependent manner (Fig. 7) . In comparison, control T cells from V␣19iTgMR1 Ϫ/Ϫ mice did not respond to recombinant IL-12. We concluded from these mechanistic studies that the innate signal IL-12 is indispensable for MAIT cell function of controlling bacterial infection. In contrast, certain effector functions of MAIT cells may be MR1 independent, in spite of the critical role of MR1 expression during development.
MR1-restricted MAIT cells play a unique role in protective immunity against mycobacterial infection in vivo. From our in vitro observations, MAIT cells appear to function as innate lymphocytes and are capable of controlling mycobacterial infection. To test the hypothesis that MAIT cells play a nonredundant role in providing immunity against infection, we infected MR1
Ϫ/Ϫ mice with a low dose of M. bovis BCG via the aerosol route. At day 10 postinfection, MR1
Ϫ/Ϫ mice showed significantly higher bacterial burdens in the lung than WT mice (Fig. 8a) . However, MR1
Ϫ/Ϫ and WT mice showed similar bacterial loads in the lung at day 30 postinfection (Fig. 8a) . These results suggest that MAIT cells contribute to controlling bacterial growth at the early stage of infection. To detect a greater cytokine response, we increased the infection dose and delivered M. bovis BCG via the intranasal route. Consistent with the result in the aerosol challenge, MR1 Ϫ/Ϫ mice had higher bacterial burden in the lung than WT mice at day 10 after intranasal infection (data not shown). Furthermore, when stimulated ex vivo with M. bovis BCG and various antigens derived from M. tuberculosis, bronchoalveolar lavage (BAL) cells from infected MR1 Ϫ/Ϫ mice showed a lower IFN-␥ response than BAL cells from WT mice (Fig. 8b) . The antigens tested included culture filtrate proteins (CF) and cell wall (CW) fractions from M. tuberculosis H37Rv. Of note, a previous study suggested that the CW fraction of M. tuberculosis stimulated CD8 ϩ human MAIT cell clones (33) . Thus, the lower IFN-␥ response of MR1 Ϫ/Ϫ BAL cells after infection may result from the lack of MAIT cells responding to mycobacterial antigens ex vivo. However, it is difficult to interpret these findings without definitive evidence that MR1 binds a ligand and, if so, whether it is microbe derived or an infectioninduced self-ligand. Alternatively, BAL cells from infected MR1 Ϫ/Ϫ mice also showed a lower IFN-␥ response to Ag85Bpp, the peptide pool of known immunodominant epitopes of Ag85B recognized by CD4 ϩ and CD8 ϩ T cells (1, 44, 53) , suggesting a poorer adaptive immune response in MR1 Ϫ/Ϫ mice during M. bovis BCG infection. Because IL-17A is known to be important for driving T H 1 immunity in the lung after the infections of intracellular pathogens (36, 46, 47, 51) , we speculated that the defective IL-17 response in MR1
Ϫ/Ϫ mice due to the lack of MAIT cells results in failure to recruit CD4 ϩ and CD8 ϩ T cells to the site of infection. In fact, BAL cells from infected MR1 Ϫ/Ϫ mice produced Results are means Ϯ SEM from triplicate assays of each set of culture conditions. Statistical analysis was performed using Student's t test. Although there was a trend for cytokine secretion of V␣19iTgMR1 ϩ/ϩ T cells to be lower in the presence of MR1 blockage, the difference was not statistically significant. Data are results from two time points in two independent experiments. less IL-17A than infected WT mice in response to the CW fraction of M. tuberculosis (Fig. 8c) . The functional relevance of the published reports that MAIT cells accumulated at the site of infections (33, 50) is supported by the evidence reported here that MAIT cells are a potentially significant source of IFN-␥ and IL-17A. In any case, the overall implication of these findings is that MAIT cells not only play a unique role among innate lymphocytes but may also predispose adaptive lymphocytes to mount protective immune responses during infection.
DISCUSSION
In this study, we provide in vitro and in vivo evidence that MAIT cells exert unique innate functions to control mycobacterial growth. In a coculture assay of purified MAIT cells and mycobacterium-infected M⌽, MAIT cells were found to curtail growth of intracellular bacterial replication associated with the secretion of IFN-␥ and IL-17A, known mediators of immunity against intracellular and extracellular bacterial infection (17, 19, 22, 42, 47, 63, 80) . Furthermore, the "first-line" production of IFN-␥ and IL-17A by innate lymphocytes is known to play an important role in bridging innate and adaptive immunity (3, 21, 36, 46, 51, 67) . Although both IFN-␥ and IL-17A of MAIT cells were induced during the coculture with mycobacterium-infected M⌽, the control of mycobacterial growth was dependent only upon IFN-␥. Thus, IL-17A secretion by MAIT cells likely has a role other than the direct impact on bacterial intracellular growth in the mycobacterial infection model used here.
Importantly, the antibacterial activity of MAIT cells in our in vitro assays was found to be critically dependent upon their in vivo development in MR1-positive mice. Although in WT mice MAIT cell development is MR1 dependent, in transgenic mice expressing the MAIT cell canonical V␣19-J␣33 TCR␣ chain, V␣19i T cells can develop in both Mr1 ϩ/ϩ and Mr1 Ϫ/Ϫ mice. However, only MR1-educated V␣19i T cells have a MR1-dependent bias in TCR␤ chain usage and exhibit effector/memory and cytokine secretion profiles like nontransgenic MAIT cells (45, 55) . In complete agreement with this conclusion from previous studies, only V␣19i transgenic T cells developing in the MR1-positive mice were found to control intracellular bacterial growth in our in vitro assays. Surprisingly, however, these MAIT cells selected by MR1 in vivo were found not to rely on MR1 engagement to impair intracellular bacterial replication in vitro. Indeed, this conclusion was Interestingly, besides infection, MAIT cells have been reported to play a regulatory role in mouse models of autoimmunity (10, 20, 58, 68) . For example, Croxford et al. showed that MAIT cells provide protection in murine autoimmune encephalomyelitis (EAE) by inducing the IL-10 production by B cells (20) . However, this protective mechanism was shown to be MR1 independent and partly ICOS dependent. More recently, Chiba et al. showed that MAIT cells adoptively transferred into MR1 Ϫ/Ϫ mice augment collagen antibody-induced arthritis (10) . To explain how MAIT cells modulate the immune response in the absence of MR1, their in vitro analyses showed that MAIT cells are stimulated to proliferate by IL-1␤ and to produce IL-17A by IL-23 in the absence of TCR signals (10) . In the present study, MAIT cells were found to release IFN-␥ by the stimulation of IL-12 in the absence of infection. In accordance with these examples of cytokine driven activation, human MAIT cells express high levels of IL-12R␤2 and IL-23R (2, 5) . These combined findings point toward a model in which, after selection by MR1 in thymus, MAIT cells are programmed to respond to innate signals, at least some of which can occur without concurrent MR1 recognition. Alternatively, after egress from the thymus, MAIT cells adapt by quickly responding to infection (34) . During infection, MR1 on either APCs or MAIT cells themselves may be a sufficient signature to allow MAIT cell activation by an innate cytokine signal.
Despite the above evidence of the non-MR1-dependent functions of MAIT cells, previously published studies have provided evidence for cognate interaction between MR1 and MAIT cells using the anti-MR1 MAbs used in this study (13, 33, (39) (40) (41) 50) . In earlier mouse studies, MAIT cell hybridomas were selected based on TCR usage, and a small fraction of these MAIT hybridomas were found to be activated by MR1-overexpressing cell lines in a manner blockable by MAbs to MR1 or TCR (13, 39, 56) . More recently, mouse MAIT cells from V␣19 TCR-transgenic mice as well as serologically isolated polyclonal human MAIT cells were found to express activation markers after culture with bacteriuminfected cells in a manner that was also blockable with anti-MR1 MAb (50) . In addition, numerous CD8 ϩ human MAIT cell clones with activity against cells infected with M. tuberculosis and other bacteria were found to be blocked by anti-MR1 MAb (33) . Although the above-mentioned studies provide compelling evidence for the occurrence of the MR1-dependent activation of MAIT cells, its overall importance relative to noncognate activa- tion is difficult to assess without a better definition of functional heterogeneity within polyclonal MAIT cells.
As a notable parallel, the studies of iNKT cells provide a precedent for how innate T cells bearing limited TCR repertoires employ multiple mechanisms to control microbial infections (6, 8, 74) . More specifically, iNKT cells react to microbial infections through at least three activation pathways: microbial antigendriven, cytokine-and self-antigen-driven, and cytokine-driven pathways (8, 74) . While microbial and self lipid antigens detected by iNKT cells have been identified (7, 8, 48, 74) , recent studies show that the dominant IL-12 signal from APCs during microbial infection occurs independently of whether microbes express CD1d-presented antigens (9, 15) . The IL-12 signal is thought to be an essential factor that enables iNKT cells to respond to a wide variety of microbes with limited TCR repertoires (8, 74 ). In the case of self-ligand recognition, IL-12 can provide costimulation to amplify a weak TCR-mediated signal (8, 9, 74) . Moreover, during viral infection, cytokines, including IL-12 and IL-18, dominate the iNKT cell activation, while CD1d presentation is not required (shown by the use of CD1d Ϫ/Ϫ mice and/or anti-CD1d MAb) (75). The constitutive expression of high levels of IL-12 receptor on iNKT cells provides an explanation for the immediate response of iNKT cells to cytokine-driven activation (9) . It is likely that, since they share many innate-type features with iNKT cells, MAIT cells are also equipped for rapid responses using cognate and noncognate pathways of activation.
By bridging innate and adaptive immune responses, innatetype T cells are critical for providing the first-line protection against infection (65) (17) .
Our in vivo findings supporting a role of MAIT cells in mycobacterial infection are congruent with published observations that MAIT cells are activated in vitro by mycobacterium-infected cells (33, 50) . Similar to our findings, Georgel et al. showed that MR1 Ϫ/Ϫ mice infected intraperitoneally with K. pneumoniae failed to control bacterial burden, and serum cytokine analysis of the infected MR1 Ϫ/Ϫ mice showed a decreased proinflammatory response compared to WT mice (32) . Again, congruent with these finding, in vitro studies showed that MAIT cells displayed activation markers after coculture with cells infected with K. pneumoniae (50) . Curiously, however, while MAIT cells also showed strong in vitro reactivity to E. coli, another member of the family Enterobacteriaceae (50), MR1 Ϫ/Ϫ mice were not defective in controlling E. coli infection via the intraperitoneal route (32) . Similarly, cells infected with M. abscessus activated MAIT cells in vitro, but MR1 Ϫ/Ϫ mice were not defective in controlling bacterial growth in vivo (50) . However, Mr1 ϩ/ϩ mice, in which all T cells expressed the transgene of invariant TCR␣ chain of MAIT cells, had lower bacterial loads after infection with E. coli or M. abscessus than Mr1
Ϫ/Ϫ mice with T cells expressing the same transgenes (50) . This finding suggested that overexpression of MAIT cells may be required to detect their in vivo functions. However, our report and the report by Georgel et al. (32) would suggest otherwise. Thus, although MAIT cells are activated by diverse microbes in vitro, we speculate that their in vivo roles are most prominent when infections are introduced into mucosal tissues, when bacterial replication in vivo allows a window to monitor innate effector function, and when appropriate innate effector functions are monitored.
Recent findings and speculations of the importance of MAIT cells raise the question of why they were not detected sooner. Indeed, MAIT cells were likely a factor in previously reported findings comparing ␤ 2 -microglobulin (␤ 2 m)-deficient mice and CD1d-, H2-M3-, or MHC class Ia-deficient mice (14, 23, 30, 70 
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Ϫ/Ϫ showed that non-H2-M3 MHC class Ib-restricted CD8 ϩ T cells express activated surface markers, exhibit cytotoxicity, and produce cytokines, including IFN-␥ and IL-17A, in response to L. monocytogenes infection (11) . Although this response was not blocked by anti-MR1 MAb, based on our findings this could be due to non-MR1-dependent activation of MAIT cells. Moreover, it is possible that the role of the MAIT cells in the CD4/CD8 DN T-cell population is overlooked in the studies focusing on CD8 ϩ T cells in Kb Ϫ/Ϫ Db Ϫ/Ϫ or Kb Ϫ/Ϫ Db Ϫ/Ϫ M3 Ϫ/Ϫ mice (11, 76) . In fact, a rare population of CD4 Ϫ CD8 Ϫ NK1.1 Ϫ ␣␤ T cells in WT mice was shown to inhibit the intracellular growth of M. tuberculosis and Francisella tularensis (LVS) (18, 19) , and these CD4/CD8 DN T cells secreted high levels of IFN-␥ and IL-17A in response to F. tularensis LVS infection (19) . These parallels between previous studies and recently defined features of MAIT cells support the notion that MAIT cells are key innate effectors against infection by diverse microbes.
To our knowledge, this study is the first to investigate the in vivo role of MAIT cells in a mucosal infection model. Evidence is provided that MAIT cells have an innate effector function and play a nonredundant role in the immune system during bacterial infection. Mechanistically, we show that MAIT cells control bacterial growth and produce proinflammatory cytokines. Further characterization of the mechanisms by which MR1 and MAIT cells are involved in the induction of protective immunity may help in the future design of vaccines against bacterial infection.
